Customized Genetic Testing Market Report 2025

The customized genetic testing market size has grown rapidly in recent years. It will grow from $12.16 billion in 2024 to $14.13 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historical period is attributed to the increased adoption of personalized medicine, a rise in genetic disorder cases, early incorporation of genetic testing in oncology and pharmacogenomics, improvements in sequencing technologies, and a growing consumer interest in ancestry and direct-to-consumer genetic testing.

The customized genetic testing market size is expected to rapid growth in the next few years. It will grow to $25.5 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The forecast growth period is driven by the decreasing cost of whole genome sequencing, broader uses in preventive healthcare, government support for genomics research, the integration of artificial intelligence in genetic data analysis, and heightened collaboration between diagnostic firms and pharmaceutical companies for targeted therapies. Key trends anticipated include a move toward at-home genetic testing kits, increased attention to polygenic risk scoring, the creation of multi-omics-based personalized healthcare solutions, greater emphasis on genetic counseling services alongside testing, and the use of blockchain technology for secure management of genetic data.

The rising adoption of personalized medicine is expected to drive the growth of the customized genetic testing market in the coming years. Personalized medicine is a healthcare approach where treatments, preventive strategies, and medical decisions are tailored to the unique characteristics of each patient. This trend is supported by advancements in genomics, proteomics, and biomarker discovery, enabling treatments based on individual genetic profiles and increasing demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Customized genetic testing is essential in this approach, offering detailed genetic insights for accurate disease risk assessment, personalized treatments, and preventive care strategies. For example, in February 2024, the Personalized Medicine Coalition, a US nonprofit organization, reported that the United States Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. As a result, the growing adoption of personalized medicine is contributing to the expansion of the customized genetic testing market.

Key companies in the customized genetic testing market are focusing on direct-to-consumer offerings, particularly at-home DNA testing combined with health plans tailored to individual genetic information. At-home DNA testing allows individuals to collect saliva or cheek swab samples outside clinical settings, typically by ordering a kit online or from a pharmacy and mailing it to a laboratory for analysis. For example, in May 2025, Hydreight Technologies Inc., a digital health technology company based in Canada, launched a personalized genetic testing and wellness service on its VSDHOne Platform. The service offers convenient access to at-home DNA testing kits and delivers customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. The platform also supports ongoing care through telehealth services and in-person consultations with licensed healthcare professionals.

In March 2025, Tempus, a precision medicine company based in the United States, acquired Ambry Genetics for an undisclosed amount. This acquisition aims to enhance Tempus’ position in the market and expand its genomic testing capabilities by combining Ambry’s experience in inherited disease diagnostics with Tempus’ artificial intelligence-driven precision medicine platform. Ambry Genetics, also based in the United States, is a prominent provider of clinical genetic testing, specializing in inherited disease diagnostics, cancer risk assessment, and next-generation sequencing technologies that support precision healthcare.

Major players in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics.

North America was the largest region in the customized genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in customized genetic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the customized genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Customized genetic testing is a personalized method of genetic analysis that selects specific genes, variants, or DNA regions to examine based on an individual’s unique needs, such as medical history, family health background, ethnicity, or particular clinical concerns. This testing targets the genes most relevant to the patient’s situation, enabling more accurate risk assessment, diagnosis, and management. Customized genetic testing helps identify inherited conditions, guide treatment decisions, and support choices in areas such as disease prevention, reproductive planning, and personalized medicine.

The primary test types of customized genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing. Predictive testing involves examining an individual’s genetic makeup to evaluate the risk of developing specific hereditary conditions before symptoms appear. It is especially valuable for conditions that manifest later in life, allowing for early interventions and informed decision-making. Samples used include saliva, blood, and buccal swabs, which are analyzed using next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray analysis, and single-cell sequencing technologies. Applications cover areas such as oncology, cardiovascular diseases, neurological disorders, and metabolic disorders, and are applied across predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing.

The customized genetic testing market research report is one of a series of new reports that provides customized genetic testing market statistics, including customized genetic testing industry global market size, regional shares, competitors with a customized genetic testing market share, detailed customized genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the customized genetic testing industry. This customized genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The customized genetic testing market includes revenues earned by entities by providing services such as personalized testing, diagnostic evaluations, and customized genomic reporting. The market value also includes the worth of related goods supplied by service providers or bundled within their offerings. Only goods and services exchanged between entities or sold directly to end consumers are accounted for in this valuation.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.